Remedium Capital Partners, LLC
- SEC CIK
- 0002104501
- Latest filing
- Aug 7, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 19, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 6
- 0 vs. Q4 2025
- Portfolio value
- $281.2M
- +$110.9M (+65.2%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | COM | 1,565,661 | $76.8M | 27.3% | +13,247+0.9% | Added | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,456,231 | $73.5M | 26.1% | 00.0% | Unchanged | History |
| DMRADamora Therapeutics, Inc. | COM NEW | 2,045,473 | $53.0M | 18.8% | +1,925,000+1,597.9% | Added | History |
| APGEApogee Therapeutics, Inc. | COM | 583,591 | $49.1M | 17.5% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM NEW | 1,577,750 | $22.2M | 7.9% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 361,250 | $6.64M | 2.4% | 00.0% | Unchanged | History |